Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII
Sunitinib (SU) is widely used to treat solid tumors but it can be cardiotoxic and often leads to drug withdrawn or discontinuation. Astragaloside IV (ASIV) is the essential active component of the Chinese herb Astragalus membranaceus which shows potential cardioprotective effects. Herein, we investi...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2024-02-01
|
| シリーズ: | Heliyon |
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2405844024008107 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
